NASDAQ:PRAH - PRA Health Sciences Stock Price, News, & Analysis

PRA Health Sciences trades on the NASDAQ under the ticker symbol "PRAH."

PRA Health Sciences Inc (NASDAQ:PRAH) announced its quarterly earnings results on Wednesday, October, 31st. The medical research company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.06. The medical research company earned $717.60 million during the quarter, compared to the consensus estimate of $729.63 million. PRA Health Sciences had a net margin of 5.36% and a return on equity of 26.55%. The company's revenue for the quarter was up 23.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.88 earnings per share. View PRA Health Sciences' Earnings History.

PRA Health Sciences is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for PRA Health Sciences.

PRA Health Sciences will be holding an earnings conference call on Thursday, May 2nd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8779308062.

PRA Health Sciences issued an update on its FY19 earnings guidance on Wednesday, February, 27th. The company provided earnings per share guidance of $4.93-5.08 for the period, compared to the Thomson Reuters consensus estimate of $4.92. The company issued revenue guidance of $3.09-3.20 billion, compared to the consensus revenue estimate of $3.18 billion.PRA Health Sciences also updated its Q1 guidance to $1.05-1.10 EPS.

9 brokers have issued 12 month price objectives for PRA Health Sciences' shares. Their predictions range from $100.00 to $122.00. On average, they expect PRA Health Sciences' share price to reach $114.25 in the next year. This suggests a possible upside of 19.6% from the stock's current price. View Analyst Price Targets for PRA Health Sciences.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PRA Health Sciences in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PRA Health Sciences.

News headlines about PRAH stock have been trending somewhat positive recently, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. PRA Health Sciences earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned news headlines about the medical research company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the near future.

Some companies that are related to PRA Health Sciences include Incyte (INCY), EXACT Sciences (EXAS), Icon (ICLR), Charles River Laboratories Intl. (CRL), Exelixis (EXEL), Syneos Health (SYNH), BTG (BTGGF), Medpace (MEDP), Intrexon (XON), Eloxx Pharmaceuticals (ELOX), Sorrento Therapeutics (SRNE), STARPHARMA HOLD/S (SPHRY), Pieris Pharmaceuticals (PIRS), Anavex Life Sciences (AVXL) and Luna Innovations (LUNA).

Based on aggregate information from My MarketBeat watchlists, some companies that other PRA Health Sciences investors own include Mattel (MAT), Ultra Clean (UCTT), General Electric (GE), Twitter (TWTR), US Foods (USFD), American National BankShares (AMNB), Enterprise Bancorp (EBTC), Alibaba Group (BABA), New York Times (NYT) and General Motors (GM).

(PRAH) raised $306 million in an IPO on Thursday, November 13th 2014. The company issued 17,000,000 shares at a price of $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities acted as the underwriters for the IPO and Baird and William Blair were co-managers.

PRA Health Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Strs Ohio (0.45%), South Texas Money Management Ltd. (0.41%), Retirement Systems of Alabama (0.24%), Chartwell Investment Partners LLC (0.11%), Scout Investments Inc. (0.09%) and Bellecapital International Ltd. (0.07%). Company insiders that own PRA Health Sciences stock include Colin Shannon, David W Dockhorn, Linda Baddour, Matthew P Young and Pra Investors LP Kkr. View Institutional Ownership Trends for PRA Health Sciences.

PRAH stock was sold by a variety of institutional investors in the last quarter, including Avalon Advisors LLC, Bellecapital International Ltd., Investec Asset Management LTD, Meeder Asset Management Inc., Scout Investments Inc., Eqis Capital Management Inc., First Bank & Trust and State of Alaska Department of Revenue. View Insider Buying and Selling for PRA Health Sciences.

PRAH stock was bought by a variety of institutional investors in the last quarter, including Strs Ohio, Retirement Systems of Alabama, South Texas Money Management Ltd., Bowling Portfolio Management LLC, Creative Planning, Chartwell Investment Partners LLC, Toth Financial Advisory Corp and Brinker Capital Inc.. View Insider Buying and Selling for PRA Health Sciences.

Shares of PRAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRAH stock can currently be purchased for approximately $95.51.

PRA Health Sciences has a market capitalization of $6.27 billion and generates $2.87 billion in revenue each year. The medical research company earns $153.90 million in net income (profit) each year or $3.93 on an earnings per share basis. PRA Health Sciences employs 16,400 workers across the globe.

The official website for PRA Health Sciences is http://www.prahs.com.

PRA Health Sciences' mailing address is 4130 PARKLAKE AVENUE SUITE 400, RALEIGH NC, 27612. The medical research company can be reached via phone at 919-786-8200 or via email at [email protected]